Q3 2023 · 13F-HR
NEA Management Company, LLCholdings as filed
Filed 2023-11-14 · accession 0001012975-23-000460
$1.29B
Reported value
46
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 22266M104 | COUR | COURSERA INC | $240.5M | 18.6% | 12,867,769 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $134.4M | 10.4% | 3,745,262 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $92.5M | 7.14% | 24,471,264 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $91.0M | 7.03% | 5,108,563 | Common | SOLE |
| H17182108 | CRSP | CRISPR THERAPEUTICS AG | $72.1M | 5.57% | 1,587,854 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $69.1M | 5.34% | 2,186,243 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $66.7M | 5.15% | 2,909,956 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $48.3M | 3.73% | 22,776,409 | Common | SOLE |
| 65345N106 | NN | NEXTNAV INC | $42.1M | 3.25% | 8,189,156 | Common | SOLE |
| 61225M102 | GLUE | MONTE ROSA THERAPEUTICS INC | $36.8M | 2.85% | 7,692,298 | Common | SOLE |
| 75974E103 | — | RENEO PHARMACEUTICALS INC | $36.4M | 2.81% | 4,785,494 | Common | SOLE |
| 126638105 | CVRX | CVRX INC | $36.0M | 2.78% | 2,370,542 | Common | SOLE |
| 15102K100 | CELC | CELCUITY INC | $31.8M | 2.46% | 1,250,001 | Common | SOLE |
| 05156V102 | AUPH | AURINIA PHARMACEUTICALS INC | $30.8M | 2.38% | 3,969,834 | Common | SOLE |
| 786700104 | SGMT | SAGIMET BIOSCIENCES INC | $27.1M | 2.09% | 3,850,275 | Common | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $24.8M | 1.91% | 11,370,376 | Common | SOLE |
| 25058X105 | — | DESKTOP METAL INC | $21.0M | 1.62% | 14,407,594 | Common | SOLE |
| 98420X103 | ASNSUSD | X4 PHARMACEUTICALS INC | $16.3M | 1.26% | 14,986,793 | Common | SOLE |
| 10920V404 | — | BRIGHT HEALTH GROUP INC | $16.3M | 1.26% | 2,726,917 | Common | SOLE |
| 98955G103 | — | ZEROFOX HLDGS INC | $15.9M | 1.23% | 18,068,513 | Common | SOLE |
| 01671P100 | ALLKGUSD | ALLAKOS INC | $14.0M | 1.08% | 6,147,260 | Common | SOLE |
| 00653A107 | ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | $13.3M | 1.03% | 17,079,778 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $13.1M | 1.01% | 15,727,942 | Common | SOLE |
| 09203E105 | BDTX | BLACK DIAMOND THERAPEUTICS INC | $12.8M | 0.99% | 4,448,757 | Common | SOLE |
| 71722W107 | PHAT | PHATHOM PHARMACEUTICALS INC | $12.2M | 0.95% | 1,276,595 | Common | SOLE |
| 15870P307 | CSBR | CHAMPIONS ONCOLOGY INC | $10.6M | 0.82% | 1,713,720 | Common | SOLE |
| 45790W108 | — | INOZYME PHARMA INC | $10.2M | 0.79% | 2,437,689 | Common | SOLE |
| 90114C107 | TUYA | TUYA INC | $7.6M | 0.59% | 4,934,640 | Common | SOLE |
| 38000Q102 | GLYCEUR | GLYCOMIMETICS INC | $7.1M | 0.55% | 4,764,440 | Common | SOLE |
| 46124U107 | IVA | INVENTIVA SA | $6.3M | 0.49% | 1,462,586 | Common | SOLE |
| 12430A102 | — | BUZZFEED INC | $5.9M | 0.45% | 15,333,892 | Common | SOLE |
| 60343F106 | — | MINERVA SURGICAL INC | $5.7M | 0.44% | 34,437,052 | Common | SOLE |
| 65487U108 | NKTX | NKARTA INC | $5.0M | 0.38% | 3,568,781 | Common | SOLE |
| 57055L206 | MRKR | MARKER THERAPEUTICS INC | $4.9M | 0.38% | 1,071,428 | Common | SOLE |
| 004890109 | ACRV | ACRIVON THERAPEUTICS INC | $4.1M | 0.32% | 430,252 | Common | SOLE |
| 75915K200 | — | REGULUS THERAPEUTICS INC | $2.7M | 0.21% | 1,945,579 | Common | SOLE |
| 528872302 | LXRX | LEXICON PHARMACEUTICALS INC | $2.6M | 0.20% | 2,382,286 | Common | SOLE |
| N01045108 | — | AFFIMED NV | $2.1M | 0.16% | 4,426,488 | Common | SOLE |
| 81726A100 | — | SENTI BIOSCIENCES INC | $1.8M | 0.14% | 4,426,151 | Common | SOLE |
| 45175G108 | — | IKENA ONCOLOGY INC | $707,200 | 0.05% | 181,473 | Common | SOLE |
| 87166L209 | SYBX | SYNLOGIC INC | $614,605 | 0.05% | 281,929 | Common | SOLE |
| 868927104 | — | SURF AIR MOBILITY INC | $610,199 | 0.05% | 440,418 | Common | SOLE |
| 00654J107 | — | ADDEX THERAPEUTICS LTD | $408,293 | 0.03% | 180,000 | Common | SOLE |
| 96328L205 | 2CH | WHEELS UP EXPERIENCE INC | $219,679 | 0.02% | 106,126 | Common | SOLE |
| 270087208 | — | EARGO INC | $188,760 | 0.01% | 86,946 | Common | SOLE |
| 00972G207 | — | AKARI THERAPEUTICS PLC | $89,303 | 0.01% | 22,608 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.